D-0926-2017 Class III Terminated

Recalled by Sanofi-Aventis U.S. LLC — Bridgewater, NJ

Recall Details

Product Type
Drugs
Report Date
July 5, 2017
Initiation Date
June 12, 2017
Termination Date
February 7, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2980 bottles

Product Description

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

Reason for Recall

Superpotent Drug: high out-of-specification result for magnesium.

Distribution Pattern

Nationwide in the USA, Puerto Rico, and the United Kingdom.

Code Information

Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19